Proactive Investors : CFO ‘very encouraged’ with stroke study results
Proactive Investors : CFO discusses recent Lancet article on stroke disability treatment
CFO comments on publication of positive pre-clinical data fron retinitis pigmentosa programme
CFO gives interview at Edison
First Retinal Patient Receives Stem-Cell Therapy in ReNeuron’s Clinical Trial
For the article published by the Foundation for Fighting Blindness Click here..
BBC Breakfast interviews patient in ReNeuron’s Phase II stroke clinical trial
Interview with Dr. Michael Young, pre-clinical investigator with ReNeuron’s hRPC retinal technology
Interview with Dr. Eric Pierce, Principal Investigator on ReNeuron’s Phase I/II clinical trial for Retinitis Pigmentosa
Pro-Active Investors : ReNeuron making good progress in clinical trials, says CFO
BBC News reports on patient treated in ReNeuron Phase II stroke clinical trial
A great-grandfather becomes one of the first in the UK to be treated for a stroke, using stem cells.
Watch video: http://www.bbc.co.uk/news/health-36450628.